advertisement

Topcon

Pfeiffer N 12

Showing records 1 to 12 | Display all abstracts from Pfeiffer N

61132 A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma
Pfeiffer N
Ophthalmology 2015; 122: 1283-1293
61750 Basic biochemical processes in glaucoma progression
von Thun Und Hohenstein-Blaul N
Ophthalmologe 2015; 112: 395-401
61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Bell K
BMC Ophthalmology 2015; 15: 64
61750 Basic biochemical processes in glaucoma progression
Kunst S
Ophthalmologe 2015; 112: 395-401
61132 A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma
Garcia-Feijoo J
Ophthalmology 2015; 122: 1283-1293
61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Wilding C; Funke S
BMC Ophthalmology 2015; 15: 64
61132 A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma
Martinez-de-la-Casa JM
Ophthalmology 2015; 122: 1283-1293
61750 Basic biochemical processes in glaucoma progression
Pfeiffer N; Grus FH
Ophthalmologe 2015; 112: 395-401
61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Pfeiffer N
BMC Ophthalmology 2015; 15: 64
61132 A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma
Larrosa JM; Fea A
Ophthalmology 2015; 122: 1283-1293
61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Grus FH
BMC Ophthalmology 2015; 15: 64
61132 A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma
Lemij H; Gandolfi S; Schwenn O; Lorenz K; Samuelson TW
Ophthalmology 2015; 122: 1283-1293

Issue 17-1

Change Issue


advertisement

Oculus